Quantum Biopharma Class B Subordinate Voting Shares
QNTM
20 hedge funds and large institutions have $1.38M invested in Quantum Biopharma Class B Subordinate Voting Shares in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 6 closing their positions.
167% more capital invested
Capital invested by funds: $515K → $1.38M (+$862K)
124% more call options, than puts
Call options by funds: $269K | Put options by funds: $120K
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
18% more funds holding
Funds holding: 17 → 20 (+3)
2.5% more ownership
Funds ownership: 0.8% → 3.3% (+2.5%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$1.31M |
| 2 |
VF
Virtu Financial
New York
|
+$83.8K |
| 3 |
Millennium Management
New York
|
+$36.3K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$22K |
| 5 |
Renaissance Technologies
New York
|
+$17.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$74.6K |
| 2 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
-$67K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
-$20.8K |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$16K |
| 5 |
Morgan Stanley
New York
|
-$2K |
QNTM Hedge Fund Activity: Q4 2021 in Review
20 of the 6,519 institutional investors tracked by Wall St. Rank reported a position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) for Q4 2021, worth a combined $1.38M — up 167% from $515K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new QNTM positions and 6 closed out — a net gain of 3 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Mirae Asset Global Investments, opening a new position worth an estimated $1.31M. The largest seller was Susquehanna International Group, cutting an estimated $74.6K.
- 20 institutional investors held Quantum Biopharma Class B Subordinate Voting Shares (QNTM) as of Q4 2021, up from 17 in Q3 2021.
- Funds reported $1.38M of Quantum Biopharma Class B Subordinate Voting Shares stock for Q4 2021, up 167% quarter-over-quarter.
- 9 funds opened new Quantum Biopharma Class B Subordinate Voting Shares positions in Q4 2021 and 6 closed out, a net change of +3 holders.
- The largest Quantum Biopharma Class B Subordinate Voting Shares buyer in Q4 2021 was Mirae Asset Global Investments, an estimated $1.31M added.
- The largest Quantum Biopharma Class B Subordinate Voting Shares seller in Q4 2021 was Susquehanna International Group, an estimated $74.6K sold.
Based on aggregated 13F filings for Q4 2021.